Uncategorized

AACR: Endeavoring to go global, Zai Lab offers reality check on China’s biotech ascent

Published

2 months ago

on

Since its 2014 founding, Zai Lab has built its business by licensing drugs from Big Pharma. But in the last three years, the company has sought to leverage its footholds in China and the U.S. to become a multinational biopharma in its own right.

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version